Remote Monitoring of Home Exercise in Peripheral Arterial Disease
NCT ID: NCT05209724
Last Updated: 2022-01-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
56 participants
INTERVENTIONAL
2021-11-21
2023-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exercise Therapy for PAD Using Mobile Health
NCT04889105
Telehealth to Improve Functional Status and Quality of Life in Veterans With PAD
NCT05048979
Exercise and Weight Loss in PAD
NCT02607033
REVASC-PAD: REstricted VASCular Exercise for Peripheral Arterial Disease - A Feasibility Study at University of Tennessee Medical Center
NCT07223437
The Effect of Exercise Training on Skeletal Muscle Metabolism in Peripheral Artery Disease (PAD)
NCT01231360
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Provider Supervised
Digital monitoring system with provider supervision
Provider supervision/ feedback
Provider supervision/ feedback provided before and after walking sessions
Self Supervised
Digital monitoring system without provider supervision
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Provider supervision/ feedback
Provider supervision/ feedback provided before and after walking sessions
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of PAD (based on ABI \<0.9 in either leg or prior intervention) with mild/moderate claudication
Exclusion Criteria
* Wheelchair bound
* Inability to walk \>200m during 6 min walk test
* Use of walking aid other than cane
* Walking impairment for reason other than PAD
* Critical limb ischemia
* Planned vascular surgery within next 3 months, recent surgery within past 3 months
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dallas VA Medical Center
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Subhash Banerjee
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Subhash Banerjee, MD, MBA
Role: PRINCIPAL_INVESTIGATOR
Dallas VA Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dallas North Texas Veterans Affairs Hospital
Dallas, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1602740
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.